The effects of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2 pilot randomised controlled trial by Molassiotis, Alex et al.
Bond University
Research Repository
The effects of a family-centered psychosocial-based nutrition intervention in patients with
advanced cancer: the PiCNIC2 pilot randomised controlled trial
Molassiotis, Alex; Brown, Teresa; Cheng, Hui Lin; Byrnes, Angela; Chan, Raymond Javan;
Wyld, David; Eastgate, Melissa; Yates, Patsy; Marshall, Andrea P.; Fichera, Rebecca;








Publisher's PDF, also known as Version of record
Licence:
CC BY
Link to publication in Bond University research repository.
Recommended citation(APA):
Molassiotis, A., Brown, T., Cheng, H. L., Byrnes, A., Chan, R. J., Wyld, D., Eastgate, M., Yates, P., Marshall, A.
P., Fichera, R., Isenring, L., To, K. F., Ko, P. S., Lam, W., Lam, Y. F., Au, L. F., & Lo, R. S-K. (2021). The effects
of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2
pilot randomised controlled trial. Nutrition Journal, 20(1), [2]. https://doi.org/10.1186/s12937-020-00657-2
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
For more information, or if you believe that this document breaches copyright, please contact the Bond University research repository
coordinator.
Download date: 18 Jun 2021
RESEARCH Open Access
The effects of a family-centered
psychosocial-based nutrition intervention in
patients with advanced cancer: the PiCNIC2
pilot randomised controlled trial
Alex Molassiotis1* , Teresa Brown2, Hui Lin Cheng1*, Angela Byrnes2, Raymond Javan Chan3,4, David Wyld2,3,5,
Melissa Eastgate2,5, Patsy Yates3, Andrea P Marshall6,7, Rebecca Fichera2, Liz Isenring8, Ki Fung To1, Po Shan Ko9,
Wang Lam10, Yuk Fong Lam10, Lai Fan Au11 and Raymond See-kit Lo11
Abstract
Background: Malnutrition in advanced cancer patients is common but limited and inconclusive data exists on the
effectiveness of nutrition interventions. Feasibility and acceptability of a novel family-based nutritional psychosocial
intervention were established recently. The aims of this present study were to assess the feasibility of undertaking a
randomised controlled trial of the latter intervention, to pilot test outcome measures and to explore preliminary
outcomes.
Methods: Pilot randomised controlled trial recruiting advanced cancer patients and family caregivers in Australia and
Hong Kong. Participants were randomised and assigned to one of two groups, either a family-centered nutritional
intervention or the control group receiving usual care only. The intervention provided 2–3 h of direct dietitian contact
time with patients and family members over a 4–6-week period. During the intervention, issues with nutrition impact
symptoms and food or eating-related psychosocial concerns were addressed through nutrition counselling, with a focus
on improving nutrition-related communication between the dyads and setting nutritional goals. Feasibility assessment
included recruitment, consent rate, retention rate, and acceptability of assessment tools. Validated nutritional and quality
of life self-reported measures were used to collect patient and caregiver outcome data, including the 3-day food diary,
the Patient-Generated Subjective Global Assessment Short Form, the Functional Assessment Anorexia/Cachexia scale,
Eating-related Distress or Enjoyment, and measures of self-efficacy, carers’ distress, anxiety and depression.
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Results: Seventy-four patients and 54 family caregivers participated in the study. Recruitment was challenging, and for
every patient agreeing to participate, 14–31 patients had to be screened. The consent rate was 44% in patients and 55%
in caregivers. Only half the participants completed the trial’s final assessment. The data showed promise for some patient
outcomes in the intervention group, particularly with improvements in eating-related distress (p = 0.046 in the Australian
data; p = 0.07 in the Hong Kong data), eating-related enjoyment (p = 0.024, Hong Kong data) and quality of life (p = 0.045,
Australian data). Energy and protein intake also increased in a clinically meaningful way. Caregiver data on eating-related
distress, anxiety, depression and caregiving burden, however, showed little or no change.
Conclusions: Despite challenges with participant recruitment, the intervention demonstrates good potential to have
positive effects on patients’ nutritional status and eating-related distress. The results of this trial warrant a larger and fully-
powered trial to ascertain the effectiveness of this intervention.
Trial registration: The trial was registered with the Australian & New Zealand Clinical Trials Registry, registration number
ACTRN12618001352291.
Keywords: Malnutrition, Anorexia, Advanced cancer, Eating-related distress, Quality of life, Caregivers
Background
Inadequate food intake and weight loss, which are asso-
ciated with risk of malnutrition, frequently occurs
among cancer patients. Those at advanced stages of can-
cer are particularly vulnerable to severe malnutrition
due to complex pathophysiological factors including
tumor-induced inflammatory responses and metabolic
disorders [1]. Studies have reported that 52–61% of ad-
vanced cancer patients experience moderate to severe
malnutrition [2, 3]. These patients also experience a
multitude of nutrition impact symptoms, such as an-
orexia, fatigue, and dry mouth, which can cause eating-
related distress [4]. Similarly, family caregivers can be
distressed by the patients’ nutritional problems, which
are seldom addressed by healthcare providers [5, 6]. For
both patients and caregivers, food is not only important
in terms of nutritional value but also in terms of its psy-
chosocial meaning. This psychosocial function is often
not well addressed in oncology nutritional care [7].
According to the most recent European Society for
Clinical Nutrition and Metabolism guideline, it is recom-
mended that dietary counselling and/or oral nutritional
supplements is the first line treatment to prevent and
manage malnutrition and includes advice to increase
food intake, symptom management and address eating-
related distress for advanced cancer patients who are
malnourished or at risk of malnutrition [8]. However,
such recommendations have not been empirically vali-
dated. Current nutrition interventions for advanced can-
cer patients have focused primarily on provision of
dietary advice and/or oral nutritional supplements, and
research findings relating to these interventions are in-
conclusive [9, 10]. Additionally, researchers have
attempted to develop and test psychosocial-based nutri-
tion interventions in advanced cancer patients in the
past, although effectiveness data have not yet been re-
ported [11, 12].
A qualitative synthesis found that malnutrition in cancer
patients has physical, psychological, social and spiritual
consequences [13]. Patients reported struggling with
weight loss or being pressured by the family to eat [13],
they felt they did not receive appropriate dietary advice,
and they are often self-managing their weight loss. In
addition, cancer patients largely rely on their families for
support and family caregivers wish to be actively engaged
in the patient’s nutrition care [13]. One study has identi-
fied that incorporating family members in the provision of
cancer care can have positive effects in reducing anxiety
and depression for patients and families [14].
Therefore, a family-centred, psychosocial-based nutrition
intervention for advanced cancer patients experiencing or
at-risk of malnutrition with the involvement of family care-
givers was developed by utilising the team’s expertise in pal-
liative home care for advanced cancer patients and previous
qualitative work [13]. The intervention was guided by the
Family Systems Theory, with two important features being
goal setting and self-regulation [15]. The rationale for fam-
ily inclusion in nutritional care is that family caregivers can
be empowered with nutritional knowledge and skills by
healthcare providers in order to optimize their competency
and support for the patient and improve adherence to the
intervention [15, 16]. Through nutrition education and
counselling approaches, patients and family caregivers
worked together towards improvement in the patients’ nu-
tritional intake and weight, thereby potentially enhancing
quality of life. The intervention, using two different ap-
proaches, was successfully tested in a single-arm pre-post
experimental study for evaluating its acceptability and feasi-
bility through surveys and interviews with various stake-
holders [17, 18].
Building on the success of the feasibility study and in-
formed by the Medical Research Council recommenda-
tions for the evaluation of complex interventions [19],
the aim of the present study was to assess the feasibility
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of undertaking a RCT to pilot test outcome measures
and to explore preliminary effectiveness before a larger




This study was a two-arm, non-blinded pilot RCT. The
experimental group received the family-centred
psychosocial-based nutrition intervention, and the con-
trol group received usual care involving some nutritional
advice and symptom management by the cancer care
teams. .
Sample and settings
The sample included a heterogeneous group of ambula-
tory patients with advanced cancer, identified at risk of
malnutrition, with or without their caregivers at the
Royal Brisbane and Women’s Hospital (Australian site)
and Haven of Hope Hospital and Shatin Hospital (Hong
Kong sites). As there is no standard sample size calcula-
tion for a pilot RCT, we planned to recruit 30 subjects
(15 per group) to meet the minimal requirement for
testing the adequacy of instruments and outcome mea-
surements [20, 21].
Inclusion criteria
For patients, criteria included (1) aged≥18 years old, (2)
stage III or IV cancer, (3) with life expectancy of ≥6
months at the opinion of the treating medical oncologist,
(4) at risk of malnutrition from any cause (≥2 assessed
by the Malnutrition Screening Tool, MST), (5) capable
of oral food intake, (6) Eastern Cooperative Oncology
Group (ECOG) score 0–2, (7) living at home with a
carer (Hong Kong sites) and with or without a carer
(Australian site), and (8) able to communicate in English
(Australian site) or Chinese (Hong Kong sites) and
complete the study questionnaires with or without
assistance.
For caregivers, criteria included (1) aged≥18 years old,
(2) a family member (e.g. husband/wife, children, rela-
tives), or someone who is designated to take care of the
patient and who visits for at least 1 h per day on most
days, (3) able and willing to provide regular assistance
with meals and/or nutritional support at home (ideally
being present for 2 or more meals each day), and (4)
able to communicate in English (Australian site) or
Chinese (Hong Kong sites) and fill in the study
questionnaires.
Exclusion criteria
Patients were excluded if they were (1) completely nil by
mouth or participating in other types of nutrition
intervention research or receiving enteral/parenteral nu-
trition; (2) unable to give informed consent and commu-
nicate with the study team, (3) currently under the
active care of a dietitian with a follow up appointment
scheduled.
Randomisation
The randomisation sequence was generated in advance
using a computer-generated randomisation program.
The assignment was sequentially numbered in sealed en-
velopes. Following recruitment and enrolment of partici-
pants and obtaining consent for the study, the research
assistants at each site liaised with an independent re-
searcher in the team for randomisation allocation. This
independent researcher, who was not involved in
recruiting patients or delivering the intervention, was re-
sponsible for generating the randomisation sequence,
accessing the next sealed envelope and then advising the
research team to which group the patient had been allo-
cated. The research assistants who were responsible for
the data collection were the only persons who remained
blinded after assignment to intervention group.
Procedures
Patients attending the medical oncology cancer care out-
patient clinics (Australian site) or outpatient palliative
care clinics (Hong Kong sites) were screened for eligibil-
ity with the assistance of the treating oncologist and/or
clinic nurse. After their medical appointment, the re-
search assistants approached the patients for study brief-
ing and provided them with a detailed information
sheet. They discussed the study with the patient/carer to
determine if they were interested and completed screen-
ing to confirm full eligibility, including completion of
the Malnutrition Screening Tool. If the patient/carer
met the full inclusion criteria and agreed to join the
study, eligible participants were asked to sign an in-
formed consent form prior to randomisation to the
intervention or control group. Patients allocated to the
intervention group were contacted by the intervention
dietitian and were scheduled for the intervention within
one to 2 weeks, depending on scheduling practicalities.
Patients allocated to the control group received their ap-
pointment following usual care referral processes.
Intervention
Subjects who were randomised to the intervention group
received a family-centred nutrition intervention by a
dietitian with experience in cancer care and independent
of the research team. The intervention provided three
structured sessions (2–3 h) of dietitian direct contact
time over a 4 week period, inclusive of telehealth (Aus-
tralian site only) or telephone follow-ups to monitor,
reinforce and adjust goals, with a focus on including
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family/carers in the process. The intervention for this
trial was refined based on findings from our prior feasi-
bility intervention study [17, 18]. The context of this
intervention was around nutrition impact symptoms,
quality of life and food or eating-related psychosocial
concerns in patients and caregivers through nutrition
counselling, as well as addressing nutrition-related com-
munication between the dyads, rather than solely achiev-
ing sufficient energy/protein intake which is a common
approach in traditional dietary interventions. The effect
of education and nutrition counselling was noted at sub-
sequent reviews and goals modified accordingly. All ad-
vice was individualised and goals set in conjunction with
the patient +/− the caregiver; this may have included
modifications of the diet, altered frequency of meals/
snacks and prescription of oral nutrition supplements
may have been recommended. Calorie intake was in-
creased through food fortification techniques (with high
energy/high protein foods) and/or oral nutrition
supplements.
Components of the intervention are shown in Table 1.
The intervention also included a culturally-adapted
booklet that was provided to the patients and their care-
givers (see supplementary file 1 for the English version
and supplementary file 2 for the Chinese version of the
booklet). If patients were admitted to hospital during the
intervention period, the ward dietitian provided dietetic
care to the patient whilst they were an inpatient, and the
research dietitian continued with the intervention fol-
lowing discharge.
Control group (usual care)
Subjects in the control group received usual care that
may have involved some nutrition advice and symptom
management. More specifically, in Hong Kong usual
care involved nutritional advice and symptom manage-
ment by the palliative care team in the hospitals. Referral
to a dietitian was offered when medically indicated by
physicians. An assessment was usually conducted every
4–6 weeks, depending on whether the patient achieved
improvements in dietary intake. In Australia, standard
care for patients identified with MST>/=2 was referral to
a dietitian for nutrition assessment, diagnosis and inter-
vention. This was usually completed within 2 weeks on
receipt of referral. Patients were then reviewed as clinic-
ally indicated after this initial appointment and/or nurs-
ing staff would re-refer if further concerns. In most
cases patients usually only received the one appointment
(n = 8 had 1 appointment, n = 5 had 2 and n = 2 had 3
appointments). Following completion of outcome assess-
ments, patients were given the option to participate in
the intensive dietitian-delivered nutrition counselling off
trial.
Feasibility assessment
Feasibility was assessed using the following measures: re-
cruitment rate (consented rate × 100 divided by screened
rate); consent rate (patients); retention rate (patients);
proportion of patients with available caregivers; consent
rate (caregivers); retention rate (carers), adherence to the
protocol; and acceptability of assessment tools (0–10
Table 1 Intervention content and delivery process
Date Content Duration
Week 1, Day 1 (HK); Session 1 (AUS).
(Face-to face counselling)
1. Assess patient’s nutrition status, nutrition impact symptoms and diet history including any
dietary beliefs
1–1.5 h
2. Negotiate nutritional goals with patient and caregivers
3. Answer any nutrition-related questions from patient and family/carer
4. Provide patient and family-centred nutrition counselling supplemented with relevant nu-
trition education materials
5. Liaise with multidisciplinary team for management of nutrition impact symptoms as
required
6. Make an appointment for telephone/telehealth-based reinforcement counselling
Week 3, Day 1 (HK); Session 2 (AUS).
(Reinforcement counselling via telephone
or telehealth)
1. Assess patient’s nutrition status, nutrition impact symptoms and diet history 30–60
min
2.Identify barriers/facilitators to goal achievement and adjust goal if necessary
3. Provide patient and family-centred nutrition counselling
4. Make an appointment for telephone/telehealth follow-up
Week 5, Day 1 (HK); Session 3 (AUS).
(Follow-up via telephone or telehealth)
1. Assess patient’s nutrition status, nutrition impact symptoms and diet history 30–60
min
2. Discuss nutritional goal achievement
3.Identify barriers/facilitator to inform future goal setting and adjust goal if necessary
4. Provide further patient and family-centred nutrition counselling as required
5. Discuss if patient would like ongoing care and refer into usual care as required
HK Hong Kong sites, AUS Australian site
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Likert-type scale measuring how easy and how relevant
each questionnaire is; two items).
Data collection measures
Subjects in both the experimental and control groups
were asked to complete self-reported questionnaires at
baseline and at their third scheduled session and return
via mail with pre-paid envelopes.
Socio-demographic and clinical data of patients and family
caregivers
Patients’ socio-demographic and clinical data included
age, gender, primary cancer site, metastatic sites, co-
morbidities, malnutrition screening test score and ECOG
score. Caregiver demographics included age, gender,
family relationship to patient, employment status, educa-
tion level, and annual household income.
Quality of life (patient)
The 39-item Functional Assessment of Anorexia/Cach-
exia Therapy (FAACT) scale was used to measure gen-
eral aspects of quality of life as well as specific anorexia/
cachexia-related concerns [22]. The FAACT consists of
five subscales including physical wellbeing, social well-
being, emotional well-being, functional well-being, and
anorexia-cachexia. The Chinese validated version of the
FAACT was used in the Hong Kong part of the trial
[23]. The Cronbach alpha of this scale in the Hong Kong
sample was 0.90 and in the Australian sample 0.86.
Nutritional status (patient)
The Patient-Generated Subjective Global Assessment
Short Form (PG-SGA-SF) is a validated self-reported nu-
tritional assessment tool assessingweight history, food
intake, nutrition impact symptoms, and activities and
function [24, 25]. Furthermore, energy/protein intake
was measured by using a 3-day food record (Hong Kong
sites only, as use of the food record was not viable in the
Australian site because of the telephone/telehealth
follow-up process it followed). An independent dietitian
blinded to subject group allocation estimated energy/
protein intake. Weight was measured using a weighing
scale provided to each subject on a weekly basis and
documented in kilograms (kg; Hong Kong sites only).
Eating-related distress (patient)
Two single-item measures were used to assess eating-
related distress of patients. One item was about satisfac-
tion with and enjoyment from food, which was selected
from the Chinese version of the validated McGill Quality
of Life questionnaire [26]. The other item was about dis-
tress level related to diet, which is modified based on the
item format of the validated Symptom Assessment Scale
[27]. These two items were scored on a 0–10 scale, with
higher scores indicating more eating-related concerns.
Anxiety and depression (caregivers)
The 14-item Hospital Anxiety & Depression Scale
(HADS) [28] is a commonly used screening tool to as-
sess anxiety and depression in clinical and community
populations. The validated Chinese version of HADS
was used in the Hong Kong part of the trial [29]. The
Cronbach alpha of this scale in the Hong Kong sample
was 0.82 and in the Australian sample 0.85.
Self-efficacy (caregivers)
The 21-item Caregiver Self-efficacy Scale (CaSES) as-
sesses self-efficacy for caregivers in people with ad-
vanced cancer [30]. The CaSES consists of four domains:
Resilience, Self-Maintenance, Emotional Connectivity,
and Instrumental Caregiving. The Cronbach alpha of
this scale in the Hong Kong sample was 0.92 and in the
Australian sample 0.91.
Caregiver distress (caregivers)
The Caregiver Distress Checklist is an 18-item caregiver
self-assessment scale for evaluating distress when caring
for cancer patients. It is a dichotomous scale and each
item has either yes or no answer [31]. The Cronbach
alpha of this scale in the Hong Kong sample was 0.80
and in the Australian sample 0.395.
Eating-related distress (caregivers)
The 19-item Eating-related Distress Scale was used to
measure caregiver distress related to advanced cancer
patients’ eating problems [5]. The Cronbach alpha of
this scale in the Hong Kong sample was 0.71 and in the
Australian sample 0.92. In addition, the same single-item
about distress level related to eating used by patients
was added to the caregiver questionnaire to allow a com-
parison of patients and caregivers in the level of eating-
related distress.
Data analysis
Data were entered into IBM SPSS Statistics for Windows
version 21.0 (Armonk, NY: IBM Corp). Descriptive statis-
tics were used to describe the sample profiles and out-
come results (all outcomes were continuous variables
except for caregiver distress which was categorical) Non-
parametric tests were used to conduct inferential analysis
owing to the small sample size. Bivariate analysis was done
using Chi-Square or Fisher’s exact tests. Differences in
outcomes at the two time points across the two groups
were compared using Mann-Whitney U tests. Linear
mixed-effects models were used to examine the Group x
Time (baseline to final week) interactions on patient and
caregiver outcomes. Between-group effect sizes were
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computed by calculating mean differences of groups with
unequal sample size within a pre-post-control design. A p
value of 0.05 was set as significant level.
Ethical considerations
Ethics approval was obtained from the Royal Brisbane
and Women’s Hospital Human Research Ethics Com-
mittee, ref. number HREC/2018/QRBW/43155, and
from Kowloon Central/Kowloon East and New Territor-
ies East Cluster ethics committees (ref: KC/KE-17-0173-
FR-2 and CREC:2017:563). The protocol complied with
the Declaration of Helsinki and the ICH-GCP.
Results
Sample characteristics
In the Australian site, 32 consenting patients were allo-
cated in the intervention (n = 17) and control group
(n = 15), with 11 and 15 respectively completing the
study, and 9 in each group returning by mail the final
week assessments (Fig. 1). In Hong Kong, 42 consenting
patients were allocated in the intervention (n = 17) and
control group (n = 25), with 11 and 15 respectively com-
pleting the study, and 8 and 12 respectively returning by
mail the final week assessments (Fig. 2). ECOG perform-
ance score was 1 in most patients. Most caregivers were
retired (38% in the Hong Kong sample, 46% in the Aus-
tralian sample) and the majority in both cohorts were of
lower income. Sample characteristics were balanced well
between the two groups and across sites (Table 2 for pa-
tient data and Table 3 for caregiver data).
Recruitment feasibility
Over 1000 patients were screened at the Australian site
(includes all patients attending general oncology out-
patient clinics), to identify 321 potentially eligible pa-
tients (i.e. all inclusion criteria met, but MST score still
pending), of which 72 patients then met full eligibility
criteria (i.e. MST>/=2), and 32 patients consented to
participate. For Hong Kong, where the recruitment was
in palliative care clinics, just over 600 patients were
screened, 89 met full eligibility criteria and 42 patients
consented to participate. The patient consent rates were
Fig. 1 CONSORT recruitment flow diagram (Australian site)
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44% (Australian site) and 47% (Hong Kong sites). The
retention rates (patients completing the trial) in the Aus-
tralian and Hong Kong sites were 81 and 62% respect-
ively, noting that in both sites some of the patients
completed the intervention but 14–25% failed to
complete the last set of questionnaires and return them
to the researchers. The same was the case for the care-
givers too; 17% (Australian site) and 14% (Hong Kong
site) completed their participation in the trial but failed
to return questionnaires. The proportion of patients who
had a caregiver in the Australian site was 69%. The
Hong Kong sites did not recruit patients who had no
caregiver; however, when exploring how many of the pa-
tients approached did not have a caregiver, 17% of the
screened patients reported so. For more details see
Table 4.
Acceptability of assessment tools
The acceptability of the assessment tools used (0–10-
point scale for questionnaire being easy to complete or
being relevant) was generally acceptable. In the Austra-
lian site patients’ responses for different tools varied
from a mean of 6.28–7.52 on a 0–10 scale while for the
caregivers’ tools this ranged from 5.18–8.55. In Hong
Kong this ranged from a mean of 6.62–6.86 for patients
and 6.50–7.07 for caregivers (Table 5).
Outcome assessments
The Australian data suggest that the patients’ eating-
related distress was significantly better over time in the
intervention group (P = 0.046) than in the control group,
showing a large effect size. The same was also the case
for the FAACT quality of life scale (P = 0.045, large ef-
fect size). All other outcome variables had a numerical
tendency of improvement in the intervention group that
did not reach statistical significance in this small sample,
and with small and medium effects sizes (Table 6). For
the caregivers’ data, only the Caregiver Distress Check-
list outcome improved numerically in the intervention
group with a large effect size. Changes in anxiety and de-
pression showed a negligible effect size, while the self-
efficacy scale had a small effect size but very small
change in scores.
The Hong Kong data showed that patients’ eating-
related enjoyment significantly improved in the interven-
tion group (P = 0.024, large effect size) while the item of
eating-related distress was non-significant (P = 0.07)
having a near large effect size. All other outcome
Fig. 2 CONSORT recruitment flow diagram (Hong Kong site)
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variables also showed numerically improved values with
effect sizes being large (FAACT scale), medium to large
(PG-SGA-SF) and near large effect size on the FAACT
anorexia-cachexia subscale (Table 6). Weight was
maintained in the intervention group and decreased only
around 0.5 kg in the control group. However, clinically
meaningful improvements were observed in the inter-
vention group in terms of mean energy intake (three-day
Table 2 Socio-demographic, clinical and baseline characteristics of patients in the Australian and Hong Kong sample (n = 74)









































Gender n(%) n(%) n(%) n(%) n(%) n(%)
Female 16 (50) 8 (47) 8 (53) 26 (61.9) 11 (64.7) 15 (60)
Male 16 (50) 9 (53) 7 (47) 16 (38.1) 6 (35.3) 10 (40)
Primary cancer type
Gastrointestinal 8 (25) 2 (12) 6 (40) 20 (47.6) 9 (53.1) 11 (44)
Gynaecological 3 (9) 1 (6) 2 (13) 3 (7.1) 1 (5.9) 2 (8)
Lung 2 (6) 2 (12) 0 (0) 12 (28.6) 4 (23.5) 8 (32)
Skin 4 (13) 3 (18) 1 (7) – – –
Urological 12 (38) 8 (47) 4 (27) 5 (11.9) 3 (17.6) 2 (8)
Other (e.g. breast, thyroid, unknown
primary)
3 (9) 1 (6) 2 (13) 2 (4.8) 0 2 (8)











No appetite 11 (38) 5 (33) 6 (48) 30 (71.4) 10 (58.8) 20 (66.7)
Feeling full quickly 13 (45) 9 (60) 4 (29) 16 (38.1) 5 (29.4) 11 (44)
Dry month 3 (10) 1 (7) 2 (14) 16 (38.1) 6 (35.3) 10 (62.5)
Things taste funny or have no taste 7 (24) 4 (27) 3 (21) 13 (31) 4 (23.5) 9 (36)
Smell bothers me 2 (7) 2 (13)* 0 (0)* 9 (21.4) 3 (17.6) 6 (24)
Nausea 5 (17) 5 (33) 0 (0) 8 (19) 1 (5.9) 7 (28)
Pain 6 (21) 3 (20) 3 (21) 5 (11.9) 2 (11.8) 3 (12)
Constipation 7 (24) 4 (27) 3 (21) 4 (9.5) 3 (17.6) 1 (4)
Diarrhoea 3 (10) 2 (13) 1 (7)
Problems with swallowing 2 (7) 1 (7) 1 (1) 4 (9.5) 3 (17.6) 1 (4)
Mouth sores 1 (3) 0 (0) 1 (7)
Vomiting 2 (7) 2 (13) 0 (0) 3 (7.1) 1 (5.9) 2 (8)
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food diary assessment at week 5 shows 178 kcal more
than the same assessment at baseline; large effect size)
and mean protein intake (7.5 g change from the three-
day food diary assessment at baseline and week 5; near
large effect size), the latter reaching p = 0.08 at week 3
mid-assessment (Table 7). In the caregivers’ dataset, only
the item on eating-related distress had a medium to
large effect, while no other outcome variable had any
meaningful score change. The caregiver data derives
from the Hong Kong sample only, as only 4 caregivers
in each completed outcome assessments in Australia,
and several had missing data, therefore these were not
fully analysed (Table 8).
There were no evident associations between patient
and caregiver eating-related distress. However, a large
number of caregivers (67% in the Australian sample and
62% in the Hong Kong sample) were deemed to experi-
ence high distress from caregiving. There were also time
by group interaction effects in the patient dataset be-
tween body mass index and PG-SGA-SF scale (p =
0.018) and eating-related enjoyment (p = 0.059, n.s.
trend) while such effects were also shown between pro-
tein intake and MST score, age and body mass index
(p < 0.001). There was also a gender effect in the FAAC
T anorexia/cachexia subscale (p = 0.03), with males
reporting more anorexia/cachexia. In the caregiver
Table 3 Socio-demographic and baseline characteristics of family caregivers in the Australian and Hong Kong sample (n = 54)



























Relationship to patient n(%) n(%) n(%) n(%) n(%) n(%)
Spouse/partner 8 (67) 4 (67) 4 (67) 21 (50) 12 (70.6) 9 (36)
Children 2 (17) 1 (17) 1 (17) 13 (31) 3 (17.6) 10 (40)
Parents 1 (8) 0 (0) 1 (17) 5 (11.9) 1 (5.9) 4 (16)
Other (i.e.close relatives) 1 (8) 1 (17) 0 (0) 3 (7.1) 1 (5.9) 2 (8)
Gender
Male 5 (42) 2 (33) 3 (50) 10 (23.8) 5 (29.4) 5 (20)
Female 7 (58) 4 (67) 3 (50) 32 (76.2) 12 (70.6) 20 (80)
Highest education completed
Elementary school 1 (9) 0 (0) 1 (20) 8 (21.4) 5 (29.4) 3 (16)
Secondary school 4 (36) 3 (50) 1 (20) 24 (57.1) 8 (47.1) 16 (64)
Tertiary education 6 (55) 3 (50) 3 (60) 9 (21.4) 4 (23.5) 5 (20)






















































































Instrumental caregiving subscale 3.3 (0.7) 3.0 (0.6) 3.6 (0.7) 2.7 (0.7) 2.8 (0.7) 2.7 (0.7)
Self-maintenance subscale 2.7 (0.9) 2.5 (1.0) 2.9 (0.8) 2.7 (0.5) 2.8 (0.5) 2.7 (0.6)
Emotional-connectivity subscale 3.4 (0.6) 3.1 (0.6) 3.6 (0.4) 2.2 (0.5) 2.4 (0.5) 2.1 (0.5)
Resilience subscale 3.3 (0.5) 3.4 (0.4) 3.1 (0.6) 2.7 (0.6) 2.8 (0.6) 2.6 (0.7)
aNo statistically significant differences in any of the variables between intervention and control group
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Table 4 Feasibility aspects of the trial and intervention fidelity




Recruitment rate (patients) 10% (32/321) 14.7%
Consent rate (patients) 44% (32/72) 47%
Retention rate (patients completing
intervention/trial)
81% (26/32) 62%
Patients returning final assessments 56% (18/32) 48%
Proportion of patients with caregiver 69% (22/32) 100% (inclusion criterion)
83% (from screened sample)
Consent rate for eligible caregivers 55% (12/22) 100% (inclusion criterion)
Retention rate (caregivers completing trial) 84% (10/12) 61%
Caregivers returning final assessments 67% (8/12) 48%
Intervention fidelity
% patients attending all (3) appointments 92% (11/12) 62%
% caregivers attending all (3) appointments 67% (4/6) 62%
Adherence of appointments to timeframe
• Session 1 (completed within 2–3 weeks
from baseline)
42% (5/12) All appointments were at fixed times through one home visiting and two
phone calls for f/u
• Session 2 (completed within 4–6 weeks
from baseline)
58% (7/12)
• Session 3 (completed within 6–8 weeks
from baseline)
50% (6/12)
% patients with treatment goal 100% 100%
Table 5 Acceptability of the measured questionnaires
Australian sample Hong Kong Sample
Questionnaires Mean (SD) Range Mean (SD) Range
Patientsa
PG-SGA-SF: easy 7.52 (2.35) 0–10 6.62 ± 1.64 5–10
PG-SGA-SF: relevant 6.79 (2.69) 0–10 6.76 ± 1.67 5–10
Eating-related distress/enjoyment (single item): easy 7.97 (2.21) 0–10 6.61 ± 1.71 5–10
Eating-related distress/enjoyment (single item): relevant 6.28 (3.18) 0–10 6.86 ± 1.66 5–10
FACCT: easy 7.99 (2.21) 0–10 6.62 ± 1.62 4–10
FACCT: relevant 6.57 (3.04) 0–10 6.81 ± 1.71 5–10
Caregiversa
CDC: easy 8.55 (2.16) 3–10 6.86 ± 2.15 0–10
CDC: relevant 6.27 (3.38) 0–10 6.67 ± 1.98 3–10
ERDQ: easy 6.70 (3.62) 1–10 6.79 ± 1.83 4–10
ERDQ: relevant 5.18 (4.24) 0–10 6.79 ± 1.72 4–10
HADS: easy 6.90 (3.45) 1–10 7.07 ± 1.92 3–10
HADS: relevant 6.50 (3.44) 0–10 6.60 ± 2.07 2–10
CaSES: easy 8.09 (2.43) 2–10 6.50 ± 1.98 0–10
CaSES: relevant 6.91 (3.08) 0–10 6.79 ± 2.03 1–10
PG-SGA-SF Patient-Generated Subjective Global Assessment Short Form, FACCT The functional Assessment of Anorexia/Cachexia Therapy, CDC Caregiver Distress
Checklist, ERDQ Eating-related Distress Questionnaire, HADS Hospital Anxiety and Depression Scale, CaSES Caregiver Self-Efficacy Scale
a29 patients and 11 caregivers completed this assessment in the Australian sample. All patients caregivers completed this assessment in the Hong Kong sample
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dataset time by group interaction effects were shown be-
tween gender (females) and higher eating-related distress
(p = 0.032) and lower CaSES self-efficacy scale scores
(p = 0.029). There was also a trend in an effect between
eating-related distress and younger age (p = 0.059).
Discussion
This pilot randomised trial follows our previous work in
testing the acceptability and feasibility of a family-
centred psychosocial-based nutrition intervention and
shows that, while it is a difficult trial to recruit patients
to, the intervention shows potential in terms of its ability
to improve clinical outcomes and quality of life in pallia-
tive care patients. The potential benefit, however, was
less so in the caregivers. The innovative aspect of this
intervention lied not only in the amount of time spent
with the patient and the intensiveness of the interven-
tion but also in engaging family caregivers to improve
the effectiveness of dietary counselling through maxi-
mizing dietary intake, managing nutrition impact symp-
toms, and reducing eating-related distress, which is
different from traditional nutritional interventions that
have solely focused on achieving energy and protein
requirements.
Recruitment of patients to the trial was a key issue in
both countries. Recruitment in general medical oncology
clinics showed that 32 patients needed to be screened
(primarily through the clinic lists but subsequent
Table 6 Nutritional status, eating-related distress/enjoyment, and health-related quality of life of patients at baseline and week 5 in
the Australian and Hong Kong sample
Variables Australian site Hong Kong site
Intervention
group (n = 9) a
Mean (SD)
Control




















PG-SGA-SF 0.42 0.38 −0.64 0.16
Baseline 8.89 (1.20) 7.22 (0.80) 9.77 (1.20) 10.56 (0.99)
Follow up 6.11 (1.50) 6.00 (1.29) 8.70 (1.62) 12.45 (1.28)
Change from
baseline
−2.78 (1.18) −1.22 (1.28) −0.94 (1.21) 1.80 (1.42)
Eating-related distress
(single item)
1.02 0.05 −1.00 0.07
Baseline 2.89 (0.75) 2.00 (0.80) 2.61 (0.81) 3.18 (0.65)
Follow up 2.44 (0.88) 4.00 (0.96) 1.86 (1.13) 5.47 (0.86)
Change from
baseline




0.41 0.40 −1.07 0.02
Baseline 5.22 (1.15) 2.00 (1.05) 7.55 (0.87) 6.27 (0.70)
Follow up 7.44 (0.82) 5.89 (0.92) 4.45 (1.15) 6.71 (0.89)
Change from
baseline
2.22 (1.34) 3.89 (1.35) −3.13 (1.06) 0.46 (0.90)
FACCT total score 1.09 0.05 0.13 0.93
Baseline 103.54 (7.60) 105.79 (3.96) 101.64 (3.84) 92.05 (3.16)
Follow up 108.93 (8.20) 99.20 (3.74) 102.21 (5.32) 93.22 (4.20)
Change from
baseline
5.39 (3.12) −6.58 (4.35) 0.47 (6.27) 1.16 (3.96)
FACCT cachexia
subscale
0.34 0.49 0.72 0.13
Baseline 28.57 (3.04) 32.09 (2.80) 32.09 (1.32) 30.08 (1.18)
Follow up 32.72 (3.04) 34.05 (2.43) 33.90 (2.34) 32.99 (1.60)
Change from
baseline
4.15 (2.23) 1.96 (2.12) 2.75 (1.15) 2.85 (3.11)
a Estimated mean and standard error (SE) from linear mixed-effects model
b Effect size for mean differences of groups with unequal sample size within a pre-post-control design
c P value for group * time interaction of mean score using linear mixed-effects models
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eligibility of a smaller number of patients) for every 1
patient recruited, while recruitment in palliative care
clinics required 14 patients to be screened for every 1
patient recruited. Issues with recruitment in palliative
care settings are common, affected by gatekeeping, eth-
ical considerations, the disease burden experienced by
patients, limited life expectancy, the level of complexity
of an intervention and patient views on the concept of
randomisation [32–34]. Additional factors specific to
this trial affecting recruitment were the type of clinic
from which patients were recruited, family caregivers be-
ing unable to provide nutritional support to their ill rela-
tives, not being cared for at home (requirement for the
Hong Kong sites), or cognitive difficulties. Restrictive in-
clusion criteria, primarily the use of the Malnutrition
Screening Tool, was one of the key reasons that recruit-
ment was poor as patients did not always score highly
enough on this tool. Perhaps risk of malnutrition (as
measured by MST) is not an appropriate way to screen
this population of advanced cancer patients, particularly
as many of them will be at risk in the future if not now
and a more nuanced risk assessment may be needed for
the inclusion criteria. It would also be interesting to see
if an intervention like the current one is done early for
stage 4 patients when patients are well enough to
complete it; this could prevent future distress when they
are more unwell and less likely to participate in a trial or
intervention. Where possible, less restrictive inclusion
criteria, addressing patient views on research, simplifica-
tion of trial complexities and burden in a pragmatic trial
design and engaging family caregivers more effectively
can improve recruitment and retention rates in a trial.
Only half the patients completed the outcomes assess-
ments for the trial, even though 62–81% completed the
actual intervention. While this number is low, it is not
dissimilar to other palliative care trials. For example, in a
trial of supplement use, nutrition and exercise in ad-
vanced cancer patients, 489 patients were screened, 215
were eligible and 53 were recruited, for a recruitment
rate of 10.8% [35]; this trial experienced recruitment is-
sues and it did not achieve their expected sample. In an-
other trial of a multimodal nutrition intervention in
advanced cancer, the recruitment rate was 11.5%, while
compliance with the nutritional supplement component
of the trial was 48% [36]. Retention numbers could have
been higher in this trial if final assessments were col-
lected in a more timely manner, for example electronic-
ally or through a telephone interview, rather than relying
on patients/caregivers to return these assessments by
mail, which has been also discussed, among other recruit-
ment and retention strategies in international clinical tri-
als, elsewhere [37]. Furthermore, assessment of the dyadic
responses to disruption of what Hopkinson [38] describes
as ‘food connections’ may be an additional way to identify
patient-caregiver dyads that would benefit more from a
psychosocial-based nutrition intervention.
Some patients were excluded if they had no caregiver
to provide support. As the intervention showed benefits
to clinical outcomes of patients, irrespective of carer in-
volvement or not, patients without a caregiver in future
Table 7 Weight and nutritional intake of patients at baseline and week 5 (Hong Kong sample only)
Variables Intervention group (n = 8) a Control group(n = 12) a Between-group effect size b P value c
Weight (kg)
Baseline 52.63 (3.72) 52.28 (3.08)
Week 2 52.22 (3.72) −0.39 (0.51) 52.27 (3.09) −0.00 (0.42) 0.418
Week 3 52.04 (3.73) −0.60 (0.60) 51.92 (3.09) −0.36 (0.79) 0.193
Week 4 51.54 (3.73) −1.09 (0.63) 51.58 (3.09) −0.70 (0.50) 0.267
Week 5 52.80 (3.73) 0.17 (0.64) 51.80 (3.10) −0.48 (0.50) 0.05 0.148
Energy intake (kcal)*
Baseline 1078.58 (102.51) 932.14 (88.40)
Week 3 1168.70 (102.68) 94.24 (115.71) 953.83 (95.35) 23.12 (60.07) 0.115
Week 5 1255.76 (106.45) 182.81 (126.06) 876.69 (99.35) −43.49 (68.99) 0.77 0.211
Protein intake (g)*
Baseline 36.93 (3.98) 35.36 (3.46)
Week 3 40.52 (4.00) 3.63 (3.58) 37.56 (3.69) 2.78 (2.22) 0.084
Week 5 44.46 (4.09) 7.59 (3.72) 34.90 (3.76) 3.24 (2.22) 0.76 0.157
a Estimated mean and standard error (SE) from linear mixed-effects model
b Effect size for mean differences of groups with unequal sample size within a pre-post-control design
c P value for group * time interaction of mean score using linear mixed-effects models
*average daily grams or caloric intake from the 3-day food diary
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trials could also be recruited and offered the interven-
tion. Moreover, while questionnaires were easy to
complete, the mean scores indicated some level of diffi-
culty. In particular, the Eating-related Distress scale for
caregivers received the lowest score in terms of rele-
vance (=5.18/10) and a future trial should reconsider use
of this scale especially as it did not show any change in
the caregivers’ scores.
The single items of eating-related distress and eating-
related enjoyment showed significant improvements
linked with medium to large effect sizes in the patient
dataset. The same was the case for the Functional Assess-
ment of Anorexia/Cachexia Therapy. While weight did
not change over the 5 weeks of follow-up (a positive out-
come nevertheless considering the disease burden), energy
and protein intake did improve in a clinically relevant way.
For a future trial, eating-related distress or enjoyment
and/or the FAACT anorexia/cachexia subscale have dem-
onstrated clinically meaningful outcomes and should be
considered as primary outcome candidates. All other
scales used were relevant to patients and showed some de-
gree of improvement in the outcomes assessed, with a
small to medium effect size. These measures could also be
considered as potential trial outcome measures in the
future.
To further enhance the impact of the intervention in a
future trial, the content of the intervention could further
be refined and have stronger elements around some of
the areas that these scales depict, such as issues around
family/friends pressuring patients to eat, unpleasant taste
of foods, or tiredness. Furthermore, the often dynamic
meaning attached to nutrition-related problems by pa-
tients and their caregivers identified in the literature [39]
and the possibility that matched coping styles related to
nutrition problems between the dyads can enhance clin-
ical outcomes [40] could further be incorporated into
the intervention components.
The results from the caregiver dataset were less con-
vincing. Most outcomes used showed no improvements
or change, perhaps with the exception of the Caregiver
Table 8 Caregiver distress, eating-related distress, self-efficacy, anxiety and depression of family caregivers at baseline and week 5
















0.53 (0.12) 0.68 (0.10)
Week 5 0.56 (0.17) 0.04 (0.23) 0.58 (0.13) −0.10 (0.18) −0.29 0.63
Eating-related distress (single item)
Baseline
1.80 (0.84) 3.18 (0.69)
Week 5 3.35 (1.14) 1.54 (1.13) 5.27 (0.97) 2.09 (1.24) −0.74 0.76
ERDQ
Baseline
47.65 (1.93) 45.92 (1.59)
Week 5 46.80 (2.68) −0.68 (2.90) 46.64 (2.12) −0.28 (1.90) 0.17 0.66
CaSES
Baseline
2.79 (0.13) 2.62 (0.11)
Week 5 2.53 (0.16) −0.28 (0.09) 2.63 (0.14) 0.03 (0.13) 0.08 0.14
HADS_anxiety
Baseline
8.06 (0.87) 9.44 (0.72)
Week 5 8.62 (1.08) 0.57 (0.99) 9.69 (0.87) 0.25 (0.81) −0.49 0.81
HADS_depression
Baseline
7.98 (0.92) 9.52 (0.73)
Week 5 10.11 (1.11) 2.12 (1.36) 8.34 (0.89) −1.16 (0.70) 0.04 0.02
CDC Caregiver Distress Checklist, ERDQ Eating-related Distress Questionnaire, CaSES Caregiver Self-Efficacy Scale, HADS Hospital Anxiety and Depression Scale
a Estimated mean and standard error (SE) from linear mixed-effects model
b Effect size calculation was based on the between-group difference in total scores divided by pooled standard deviation
c P value for group * time interaction of mean score using linear mixed-effects models
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Distress Checklist, which should be retained in a future
trial. However, this scale showed very low reliability co-
efficients in the Australian sample, and this needs to be
carefully evaluated in a future trial. Notwithstanding that
the trial was not powered to show differences, there was
no specific content for caregivers in the intervention as
we expected that improvements in the patients’ out-
comes may have also indirectly affected the caregivers.
Future work could consider adding components that are
more directly relevant to the caregivers. Given the high
distress levels reported by caregivers in this study, it is
imperative that more focus be directed to managing this
distress. The Eating-related Distress scale that the Aus-
tralian sample identified as the least relevant demon-
strated no change over time, however it was an outcome
that somewhat improved (not significant) in the Hong
Kong caregiver sample and showed a large effect size.
This discrepancy may be cultural, as the scale was devel-
oped in Japan and may be more relevant to Asian popu-
lations than other ethnic groups. If such a focus is
included in a future trial, a brief measure may well suf-
fice to decrease the need for a relatively lengthy ques-
tionnaire. Eating-related distress is a relatively new
concept in palliative care [41] and its role in nutrition
care and in improving quality of life should be further
considered in future research.
Other limitations of this study include that the partici-
pants were a group of advanced cancer patients with dif-
ferent cancer diagnoses and treatment types. As the
severity of cachexia may be different across cancer diag-
nostic groups, future studies should consider focusing
on a single cancer diagnostic group. Furthermore, family
caregivers were not included in the intervention in one-
third of the participants in the Australian site. Hence,
the focus in this group of patients was not ‘family-
centred’ strictly speaking, although the key principles of
the intervention were followed even in the absence of
family caregivers. It is also possible, however, that even
if the patient did not have a caregiver that wanted to
participate in the trial itself, education and counselling
may also have been passed onto family members by the
patient to help support their nutrition care at home.
Conclusion
The current pilot trial provided further evidence that a
family-centred, psychosocial- based nutrition intervention
has the potential to provide benefit to patients at risk of or
already experiencing malnutrition. Findings which reflect
improvements across multiple outcome measures (quality
of life, energy/protein intake, eating-related distress,
eating-related enjoyment and nutritional status) provide
further support for the intervention. These promising re-
sults require confirmation in a fully-powered randomised
clinical trial. Considering recruitment and retention issues,
a pragmatic trial with more flexible inclusion criteria con-
ducted through multiple sites will be required. Food and
eating are culturally bound concepts and as such the con-
tent of the intervention also needs to be reflective of cul-
tural realities and preferences.
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